Johnson, M. L., Braiteh, F., Grilley-Olson, J. E., Chou, J., Davda, J., Forgie, A., . . . Hu-Lieskovan, S. (2019). Assessment of Subcutaneous vs Intravenous Administration of Anti–PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial. JAMA Oncol.
Stile di citazione ChicagoJohnson, Melissa L., et al. "Assessment of Subcutaneous Vs Intravenous Administration of Anti–PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial." JAMA Oncol 2019.
Citazione MLAJohnson, Melissa L., et al. "Assessment of Subcutaneous Vs Intravenous Administration of Anti–PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial." JAMA Oncol 2019.